On Nov. 12, 2021, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
On Nov. 12, 2021, GlaxoSmithKline and Vir Biotechnology announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase…
On Nov. 12, 2021, Lincoln Children’s Zoo announced on Facebook that their three snow leopards: Ranney, Everest and…
On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…
On Nov. 11, 2021, Roche announced that the European Medicines Agencyﾒs (EMA) Committee for Medicinal Products for Human…
On Nov. 11, 2021, Innovation Pharma reported topline results from the Companyﾒs Phase 2 clinical trial of Brilacidin…
On Nov. 10, 2021, a study by researchers at Georgia State University showed that the politicization of science…
On Nov. 10, 2021, Meridian Bioscience announced that their Revogeneﾮ SARS-CoV-2 assay was granted Emergency Use Authorization by…
On Nov. 10, 2021, the World Health Organization (WHO) announced that while reported measles cases had fallen compared…
On Nov. 10, 2021, the Biden-Harris Administration announced that it was increasing access to COVID-19 testing for Americans…
On Nov. 9, 2021, Moderna announced that it has submitted for a variation to the conditional marketing authorization…
On Nov. 9, 2021, Novan announced promising preclinical safety results with berdazimer sodium in a 14-day GLP repeat…
On Nov. 9, 2021, Inovio Pharma announced that the U.S. Food and Drug Administration (FDA) provided authorization to…
On Nov. 8, 2021, Regeneron announced that the European Commission had approved the casirivimab and imdevimab antibody cocktail,…
On Nov. 8, 2021, Amyris announced announced it had entered into a 50:50 joint venture arrangement with ImmunityBio…
On Nov. 8, 2021, Cocrystal Pharma announced that its SARS-CoV-2 main protease inhibitors showed potent in vitro pan-viral…
On Nov. 8, 2021, The U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for…
On Nov. 5, 2021, the USDA’s (USDA) National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 in two spotted…
On Nov. 5, 2021, Pfizer announced it was investigational novel COVID-19 oral antiviral candidate, PAXLOVID, significantly reduced hospitalization…
On Nov. 5, 2021, Chugai Pharmaceutical, announced that it had obtained approval from the Ministry of Health, Labour…
On Nov. 5, 2021, scientists at Oxford University announced they had identified the gene responsible for doubling the…
On Nov. 5, 2021, the U.S. Food and Drug Administration The FDA issued an emergency use authorization (EUA)…
On Nov. 4, 2021, Novavax announced the completion of its rolling submission to the World Health Organization (WHO)…
On Nov. 3, 2021, Innovation Pharma announced that the Company had received confirmation that hard lock of the…
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
On Nov. 3, 2021, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXINﾮ (developed…
On Nov. 2, 2021, OraSure Technologies announced that the EUA for its InteliSwabﾙ COVID-19 rapid tests had been…
On Nov. 2, 2021, the National Institutes of Health announced support for a four-year follow-up study on the…
On Nov. 1, 2021, for the first time in the U.S., the transmission of COVID-19 from pet parent…
On Nov. 1, 2021, Novavax announced the completion of its rolling submission to Health Canada for authorization of…